🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II trial to determine the efficacy and safety of stereotact...
Status
Completed
Location
Houston Methodist Cancer Center
Start Date
2017-07-01
Trial ID
NCT03004183
Treatments Being Tested
This is a Phase II trial to determine the efficacy and safety of in situ ge...
Status
Terminated
Location
Houston Methodist Hospital
Start Date
2017-02-15
Trial ID
NCT02831933
Treatments Being Tested
The purpose of this study is to conduct a Phase I - II clinical trial to ex...
Status
Recruiting
Location
Houston Methodist
Start Date
2007-06
Trial ID
NCT01913106
Treatments Being Tested
Study to assess the safety and efficacy of HSV-tk (gene therapy), valacyclo...
Status
Recruiting
Location
Houston Methodist Neurological Institute
Start Date
2017-12-11
Trial ID
NCT03596086
Treatments Being Tested
Phase 2a, open-label, multi-center study evaluating biomarkers and biodistr...
Status
Recruiting
Location
Academic Urology and Urogynecology of Arizona
Start Date
2025-10-30
Trial ID
NCT07332000
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of CAN-2409 immu...
Status
Active Not Recruiting
Location
Foothills Urology
Start Date
2016-05
Trial ID
NCT02768363
Treatments Being Tested
This study will evaluate the administration of AdV-tk followed by valacyclo...
Status
Completed
Location
Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital)
Start Date
2010-10
Trial ID
NCT00634231
Treatments Being Tested
This is a phase I dose escalation study of CAN-2409 plus prodrug in patient...
Status
Completed
Location
University of Pennsylvania
Start Date
2017-05-04
Trial ID
NCT03131037
Treatments Being Tested
This is a prospective phase II study to assess the efficacy and toxicity of...
Status
Recruiting
Location
Houston Methodist Hospital
Start Date
2018-08-02
Trial ID
NCT03541928
This phase III trial compares the effect of the combination of aglatimagene...
Status
Recruiting
Location
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health
Start Date
2026-06-15
Trial ID
NCT07660094
Treatments Being Tested